Clinical experience with high-dose polymyxin b against carbapenem-resistant gram-negative bacterial infections—a cohort study
10.3390/antibiotics9080451
Saved in:
Main Authors: | Cai, Y., Leck, H., Tan, R.W., Teo, J.Q., Lim, T.-P., Lee, W., Chlebicki, M.P., Kwa, A.L. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/199763 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Performance of population pharmacokinetic models in predicting polymyxin b exposures
by: Tam, V.H., et al.
Published: (2021) -
Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward?
by: Vasoo, Shawn
Published: (2018) -
In vitro Bactericidal Activities of Combination Antibiotic Therapies Against Carbapenem-Resistant Klebsiella pneumoniae With Different Carbapenemases and Sequence Types
by: Teo, Jocelyn Qi-Min, et al.
Published: (2022) -
In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against Carbapenem-resistant Acinetobacter baumannii in Singapore
by: Lim T.-P., et al.
Published: (2019) -
Optimizing hollow-fiber-based pharmacokinetic assay via chemical stability study to account for inaccurate simulated drug clearance of rifampicin
by: New, L.S., et al.
Published: (2014)